Biomarker Discovery & Validation

The utilization of Biomarkers in medication improvement has clinical advantages that lie in assessing helpful reaction or in observing and diagnosing the action of illnesses. The disclosure and approval Biomarkers fill in as new surrogate endpoints in starting phase of medication preliminaries. The parts of the biomarker improvement process incorporate capability, revelation, check, explore examine streamlining, commercialization and clinical approval. For improvement and disclosure of biomarker omics procedures like metabolomics, Transcriptomics, proteomics, and genomics are utilized and for approval of Biomarkers computational science, profiling strategies, information mining techniques and microarray information investigation can be used.

  • Biomarkers and endpoints for pain
  • Advancements in the technologies for discovery of biomarkers
  • identification and initial biological, analytical and clinical validation of pain biomarkers
  • New strategies for discovery and validation of biomarkers.

Related Conference of Biomarker Discovery & Validation

March 10-11, 2025

3rd World Congress on Oral Cancer

Paris, France
March 24-25, 2025

25th World Congress on Cancer and Diagnostics

London, UK
March 24-25, 2025

10th World Conference on Breast and Cervical Cancer

Paris, France
April 07-08, 2025

15th World Congress on Breast Cancer

Vancouver, Canada
June 16-17, 2025

26th World Congress on Cancer Summit

Amsterdam, Netherlands
July 14-15, 2025

5th World Congress on Breast Cancer

Berlin, Germany
October 20-21, 2025

21st International Conference on Cancer Research

Barcelona, Spain

Biomarker Discovery & Validation Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in